Multi-disciplinary Care for Brain Metastases

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Vermont Medical Center

About this trial

This is a health services intervention study aimed at understanding the impact of intensive multi-disciplinary care compared with standard care on patient-reported symptom outcomes and prognostic awareness in patients with brain metastases.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients of all genders must be at least 18 years of age.

Patients must have histologically confirmed, newly diagnosed brain metastases from known or suspected solid tumor primary neoplasms.

Patients must be able to accurately provide self-report data (e.g. per clinical judgment, cognitive function is intact).

Patients must be able to complete questionnaires in English.

Disqualifiers

Patients who are < 18 years of age are not eligible.

Patients who are Pregnant are not eligible.

Trial design

Design model

Parallel

Treatments tested in this trial

  • health services intervention

    Other intervention

    Health services intervention

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: Standard of CareActive comparator 1 intervention
Group B: Multidisciplinary CareExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Patient reported outcomes

Symptom burden based on patient reporting on Brain Mets Symptom Inventory

Time frame
6-12 months

Secondary outcomes

1

Feasibility

Number of % of patients able to complete protocol-specified activities

Time frame
6-12 months
2

Patient understanding of prognosis

Concordance with physician predication of prognosis

Time frame
6-12 months
3

survival

Survival outcomes for patients receiving best supportive care

Time frame
6-12 months

Other outcomes

1

Exploratory survival outcome

90 day and 1 year survival

Time frame
6-12 months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.